Untitled
esquerda


Leia a Última Edição!

II Serie Volume 33 Number 11
November 2020

E-ALERT:

menu esquerda
 
   
 
 
 
 


  1- Factors of recurrence of intraepithelial lesions of the uterine cervix.

2- Duodenoscopy and endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of biliary and pancreatic pathology.

3- Mephedrone (?Meow Meow?), The New Designer Drug of Abuse: Pharmacokinetics, Pharmacodynimics and Clinical and Forensic Issues

4- Natural history of fetal pyelocaliectasia.

5- Antidepressant drugs.

6- Erysipelas.

7- Pressure ulcer management--Evidence-based interventions.

8- Traumatic Brain Injury: Integrated Approach

9- Genital ulcers caused by sexually transmitted diseases: current therapies, diagnosis and their relevance in HIV pandemy.

10- Current management of gout.

11- Livedo vasculitis.

12- Tarlov's cyst: definition, etiopathogenesis, propaedeutic and treatment.

13- Antibiotic treatment of uncomplicated cystitis in non-pregnant women up to menopause.

14- Urolithiasis and renal colic. Therapeutic approach in urology.

15- Uterine inversion.

16- Surgical basic skills: surgical sutures.

17- Rhabdomyolysis.

18- Autoimmune lymphoproliferative syndrome.

19- Spondylodiscitis: which etiology?.

20- Autoimmune lymphoproliferative syndrome.

 
   

A Perspective About the Construction of the “Hospital de Campanha Porto.”



Recognizing the critical evolution of the pandemic, the North Section of the Portuguese Medical Association, along with the Porto City Hall, the Centro Hospitalar Universitário de São João (CHUSJ) and the Centro Hospitalar Universitário do Porto (CHUP), anticipated the need to organize and structure a complementary response in Porto. Several factors prompted this decision, namely (1) according to the fast transmission of SARS-CoV-2, the estimated capacity of hospitals in the city of Porto was thought to be insufficient to respond to the growing needs in terms of hospital admissions and Intensive Care Units; (2) the urge to isolate all positive patients for SARS-CoV-2, symptomatic and asymptomatic, regardless of the severity of disease; (3) the lack of conditions in a large number of patient’s homes to fulfill the isolation criteria; (4) the need to treat decompensated comorbidities in hospitalized symptomatic and asymptomatic patients.

Full Perspective paper here.